Health Discovery Corporation (OTCBB: HDVY) is pleased to announce a strategic partnership with Adaptive, Inc., a market leader in helping international companies and government agencies to capture, organize and manage the data they create. Founded in 2002, Adaptive is a transatlantic company with its U.S. Headquarters in Aliso Viejo, California. Companies today are faced with an explosion of the amount, complexity and importance of enterprise data. Enabling the ability to capture, analyze and manage this data is of critical importance for their business success. Adaptive has developed and sells its leading data management technology to large, complex corporations around the world. “Adaptive has been very successful in assisting large international corporations and government agencies collect, store and manage their data in a single sophisticated database," said Jeff Goins, Adaptive’s President. "Now our large global customers want to identify patterns in their newly organized data which can greatly add to the success of their business. As such, we are really excited to partner with Health Discovery Corporation, a company which has a superior pattern-recognition technology called Support Vector Machines, an award winning patent portfolio protecting their technology, and world-class mathematicians to assist our customers in their effort to generate additional significant revenues and cost savings by identifying unique patterns in their complex databases." According to Jeff Goins, Adaptive's President, "Health Discovery Corporation's technology can play a pivotal role in identifying patterns in electronic health records management, health care insurance, fraud detection (especially in the Medicaid/Medicare system), banking, customer data management, marketing, risk management and homeland security which represent a sampling of Adaptive's current customer base." “Enormous amounts of data are being created every second of every day and companies and governmental agencies need to run sophisticated pattern recognition analysis on their data to generate additional revenue sources, as well as, cost savings opportunities,” said Stephen D. Barnhill, Chairman and CEO, Health Discovery Corporation. “I see significant revenue potential for Health Discovery Corporation by applying our patented, pattern recognition technology in the area of data management and data-mining for these large international companies and government agencies which are customers of Adaptive Inc.,” said Dr. Barnhill.
“The critical first step in achieving this goal is getting structured and unstructured data well organized and prepared for the successful application of our pattern-recognition technology and that’s what Adaptive does so well,” said Dr. Barnhill. "The combination of creating well structured data and then applying pattern-recognition analysis to that data is a winning strategy."A 2005 report by IBM (NYSE: IBM) titled, “Managing data in the 21st century,” states: “Costs associated with managing and storing the burgeoning amount of enterprise wide data continue to expand exponentially. Now, more than ever, companies need to analyze their ability to backup, recover and manage that data—which is now the key business asset.” A July 2010 Wall Street Journal article titled, “Big Data, Big Growth, Big M&A,” stated: “The big data problem is getting bigger. Every enterprise data center vendor, from Oracle Corp. (NasdaqGS: ORCL) to Hewlett Packard Co. (NYSE: HPQ) sees an opportunity in solving it.” About Health Discovery Corporation Health Discovery Corporation is a molecular diagnostics company that uses advanced mathematical techniques to analyze large amounts of data to uncover patterns that might otherwise be undetectable. It operates primarily in the emerging field of personalized medicine where such tools are critical to scientific discovery. Its primary business consists of licensing its intellectual property and developing its own product line of biomarker-based diagnostic tests that include human genes and genetic variations, as well as gene, protein, and metabolic expression differences and image analysis in digital pathology and radiology. For more information, see www.healthdiscoverycorp.com. About Adaptive, Inc. Founded in 2002, Adaptive is a transatlantic company with its U.S. headquarters in Aliso Viejo, California. Adaptive’s mission is to help complex organizations adapt and support the rapidly changing IT and business environments which are driven by the ever increasing demands of compliance, regulatory pressures and governance requirements. Adaptive enables companies faced with an explosion of the amount, complexity and importance of enterprise metadata to capture, analyze and manage this metadata on a single point of truth platform. Adaptive has developed and delivers its leading semantic metadata repository technology to large, complex organizations around the world.
Adaptive has developed and delivered a single, automated framework, The Adaptive Framework, for capturing, storing, integrating, analyzing, visualizing and sharing the knowledge about an organization’s strategies, processes, semantics, stewardship, technology and other resources. Adaptive’s fundamental object-oriented design and standards based openness ensures agility in response to business requirement change. Its web-based accessibility leveraging its advanced workflow capability ensures a global platform for knowledge-sharing and better decision-making. With compliance to industry standards, the Adaptive offerings leverages existing data sources to include business intelligence, legacy, databases, ETL and various semantic modeling technologies and links the semantic relationships between these silo data sources enabling enterprises a platform for proper data governance, stewardship and change management.Adaptive’s current clients include major financial and insurance institutions, as well as federal and foreign government agencies. For more information see www.adaptive.com. Forward-Looking Statements This document contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, the accuracy of which is necessarily subject to risks and uncertainties, including, without limitation, statements regarding future performance, opportunities and investments, and anticipated results in general. From time to time the Company may make other forward-looking statements relating to other matters, including without limitation, commercialization plans and strategic partnerships. Actual results may differ materially due to a variety of factors, including, among other things, the acceptance of our approach to applying mathematics computer science and physics into the disciplines of biology, organic chemistry and medicine and our products and technologies associated with those approaches, the ability to develop or commercialize new drugs, therapies or other products based on our approaches, and other factors set forth from time to time in the Company’s Securities and Exchange Commission filings. All forward-looking statements and cautionary statements included in this document are made as of the date hereof based on information available to the Company as of the date hereof, and the Company assumes no obligation to update any forward-looking statement or cautionary statement.